Pulmonary Arterial Hypertension

Disease State Hub

Featured

Pop Quiz
Pop Quiz
07/25/2024
Pulmonary arterial hypertension is rare, but which patient population is most likely to develop the disorder? See if you know the answer by taking our pop quiz.
07/25/2024
pop quiz
pop quiz
06/17/2024
Are you familiar with the World Health Organization’s five groups of pulmonary hypertension? Find out by taking the pop quiz.
06/17/2024
Video
Video
04/15/2024

Zeenat Safdar, MD, MS

Zeenat Safdar, MD, MS
In this video, Zeenat Safdar, MD, MS, a STELLAR trial investigator, discusses the STELLAR trial results, which supported the FDA approval of sotatercept. Sotatercept is the first activin signaling inhibitor...
04/15/2024

Interactive Features

Pop Quiz
Pop Quiz
07/25/2024
Pulmonary arterial hypertension is rare, but which patient population is most likely to develop the disorder? See if you know the answer by taking our pop quiz.
07/25/2024
pop quiz
pop quiz
06/17/2024
Are you familiar with the World Health Organization’s five groups of pulmonary hypertension? Find out by taking the pop quiz.
06/17/2024
Management
Management
05/19/2022
Pulmonary hypertension (PH) affects the lungs and the heart. Do you think cardiologists alone or pulmonologists alone should manage patients with PH? Let us know by taking our poll.
05/19/2022
Hypertension
Hypertension
01/22/2022
In this “Test Your Knowledge” quiz series, Michael J. Bloch, MD, asks what is considered the most widely accepted definition of normal pulmonary arterial pressure.
01/22/2022
Hypertension
Hypertension
07/27/2021
In this “Test Your Knowledge” quiz series, Michael J. Bloch, MD, outlines a patient case of pulmonary arterial hypertension and asks you to classify the patient based on World Health Organization...
07/27/2021

Clinical Insights

Video
Video
04/15/2024

Zeenat Safdar, MD, MS

Zeenat Safdar, MD, MS
In this video, Zeenat Safdar, MD, MS, a STELLAR trial investigator, discusses the STELLAR trial results, which supported the FDA approval of sotatercept. Sotatercept is the first activin signaling inhibitor...
04/15/2024
Expert Q&A
Expert Q&A
03/23/2024

James F. List, MD, PhD

James F. List, MD, PhD
Based on findings from the Phase 3 A DUE study, Janssen Research & Development, LLC recently submitted a New Drug Application to the FDA seeking approval of an investigational once-daily, single-tablet...
03/23/2024
Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
08/23/2022
In this podcast, Ryan Tedford, MD, answers our questions about his team's latest study, which assessed the impact of the new definition of pulmonary hypertension on heart transplant outcomes. Pulmonary...
08/23/2022
Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension
05/29/2022
In this podcast, Aaron Waxman, MD, PhD, discusses the role of exercise hemodynamics in the diagnosis and treatment of pulmonary hypertension and the types of exercise that are best for...
05/29/2022
Critical Observations in Pulmonary Medicine, Ep. 3
Critical Observations in Pulmonary Medicine, Ep. 3
04/27/2022
In this episode, Dr Rizzo interviews Paul M. Hassoun, MD, Johns Hopkins School of Medicine (Baltimore MD), about his research on Pulmonary Arterial Hypertension (PAH), including its pathogenesis, the...
04/27/2022